Growth Metrics

Erasca (ERAS) Current Assets (2020 - 2026)

Erasca posted quarterly Current Assets of $253.8 million for Q1 2026, down 19.34% year-on-year from $314.6 million in Q1 2025, and down 11.34% on a QoQ basis from $286.2 million in Q4 2025.

Erasca (ERAS) has 7 years of Current Assets data on file, last reported at $253.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Current Assets fell 19.34% year-over-year to $253.8 million; the trailing twelve-month figure through Mar 2026 stood at $253.8 million (down 19.34% YoY), and the FY2025 full-year result was $286.2 million, down 7.3% from the prior year.
  • Current Assets for Q1 2026 stood at $253.8 million, down from $286.2 million in the prior quarter.
  • Across five years, Current Assets topped out at $444.5 million in Q4 2022 and bottomed at $253.8 million in Q1 2026.
  • The 5-year median for Current Assets is $320.7 million (2023), against an average of $339.5 million.
  • The widest annual swing landed in 2022, when Current Assets soared 93.33%; it then decreased 27.86% in 2023.
  • A 5-year view of Current Assets shows it stood at $444.5 million in 2022, then fell by 27.86% to $320.7 million in 2023, then declined by 3.71% to $308.8 million in 2024, then decreased by 7.3% to $286.2 million in 2025, then retreated by 11.34% to $253.8 million in 2026.
  • The last three Current Assets figures came in at $253.8 million (Q1 2026), $286.2 million (Q4 2025), and $299.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 10.37 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 37.31 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 1.25 Bn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 73.04 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 3.59 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 11.73 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 18.21 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.22 Bn
10 Erasca 4.21 Bn 3.97 Bn - 253.78 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 253.78 Mn
Dec 31, 2025 286.24 Mn
Sep 30, 2025 299.93 Mn
Jun 30, 2025 310.66 Mn
Mar 31, 2025 314.62 Mn
Dec 31, 2024 308.79 Mn
Sep 30, 2024 330.17 Mn
Jun 30, 2024 418.01 Mn
Mar 31, 2024 306.62 Mn
Dec 31, 2023 320.68 Mn
Sep 30, 2023 305.97 Mn
Jun 30, 2023 323.85 Mn
Mar 31, 2023 397.88 Mn
Dec 31, 2022 444.50 Mn
Sep 30, 2022 365.75 Mn
Jun 30, 2022 381.42 Mn
Mar 31, 2022 403.37 Mn
Dec 31, 2021 420.02 Mn
Sep 30, 2021 492.31 Mn
Jun 30, 2021 197.29 Mn
Dec 31, 2020 119.99 Mn